Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: Impact on iron status, liver injury and HCV genotype

Journal of Molecular Medicine

Volumn 81, Issue 12, 2003, Pages 780-787

  Gehrke, Sven G ^a,b   Stremmel, Wolfgang ^a   Mathes, Inge ^a   Riedel, Hans Dieter ^a   Bents, Karin ^a   Kallinowski, Birgit ^a,b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Fibrosis; Genetic polymorphisms; Hemochromatosis; Hepatitis C; Siderosis

Indexed keywords

TRANSFERRIN RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HEPATITIS C; HEPATITIS C VIRUS; HETEROZYGOSITY; HUMAN; IRON OVERLOAD; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; RISK;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; FEMALE; GENOTYPE; HEMOCHROMATOSIS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON OVERLOAD; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, TRANSFERRIN;

EID: 0346843108     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-003-0493-0     Document Type: Article

References (33)

1. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR (1992) Measurements of iron status in patients with chronic hepatitis. Gastroenterology 102:2108-2113
2. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R (1995) Iron storage, lipid peroxidation and gluthathione turnover in chronic anti-HCV positive patients. J Hepatol 22:449-456
3. Boucher E, Bourienne A, Adams P, Turlin B, Brissot P, Deugnier Y (1997) Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. Gut 41:115-120
4. Barbaro G, Di Lorenzo G, Ribersani M, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Barbarini G (1999) Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. J Hepatol 30:774-782
5. Beinker NK, Voigt MD, Arendse M, Smit J, Stander IA, Kirsch RE (1996) Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol 25:633-638
6. Hézode C, Cazeneuve C, Coué O, Roudot-Thoraval F, Lonjon I, Bastie A, Duvoux C, Pawlotsky JM, Zafrani ES, Amselem S, Dhumeaux D (1999) Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions. J Hepatol 31:979-984
7. Fargion S, Fracanzani AL, Sampietro M, Molteni V, Boldorini R, Mattioli M, Cesana B, Lunghi G, Piperno A, Valsecchi C, Fiorelli G (1997) Liver iron influences the response to interferon alpha therapy in chronic hepatitis C. Eur J Gastroenterol Hepatol 9:497-503
8. Olynyk JK, Reddy KR, Bisceglie AM, Jeffers LJ, Parker TI, Radick JL, Schiff ER, Bacon BR (1995) Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 108:1104-1109
9. Van Thiel DH, Friedlander L, Fagiuoli S, Wright HI, Irish W, Gavaler JS (1994) Response to interferon α therapy is influenced by the iron content of the liver. J Hepatol 20:410-415
10. Fontana RJ, Israel J, LeClair P, Banner BF, Tortorelli K, Grace N, Levine RA, Fiarman G, Thiim M, Tavill AS, Bonkovsky HL (2000) Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial. Hepatology 31:730-736
11. Piperno A, D'Alba R, Fargion S, Roffi L, Sampietro M, Parma S, Arosio V, Faré M, Fiorelli G (1995) Liver iron concentration in chronic viral hepatitis: a study of 98 patients. Eur J Gastroenterol Hepatol 7:1203-1208
12. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408
13. Pietrangelo A (2003) Haemochromatosis. Gut 52 [Suppl 2]:II23-II30
14. George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW (1998) Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114:311-318
15. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH (1997) Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 349:321-323
16. Bulaj ZJ, Phillips JD, Ajioka RS, Franklin MR, Griffen LM, Guinee DJ, Edwards CQ, Kushner JP (2000) Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 95:1565-1571
17. Smith BC, Grove J, Guzail MA, Day CP, Daly AK, Burt AD, Bassendine MF (1998) Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 27:1695-1699
18. Bonkovsky HL, Troy N, McNeal K, Banner BF, Sharma A, Obando J, Mehta S, Koff RS, Liu Q, Hsieh CC (2002) Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C. J Hepatol 37:848-854
19. Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley KV (2003) Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology 124:318-326
20. Erhardt A, Maschner-Olberg A, Mellenthin C, Kappert G, Adams O, Donner A, Willers R, Niederau C, Häussinger D (2003) HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. J Hepatol 38:335-342
21. Kazemi-Shirazi L, Datz C, Maier-Dobersberger T, Kaserer K, Hackl F, Polli C, Steindl PE, Penner E, Ferenci P (1999) The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 116:127-134
22. Martinelli ALC, Franco RF, Villanova MG, Figueiredo JFC, Secaf M, Tavella MH, Ramalho LNZ, Zucoloto S, Zago MA (1999) Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection? Acta Haematol 102:152-156
23. Negro F, Samii K, Rubbia-Brandt L, Quadri R, Male PJ, Zarski JP, Baud M, Giostra E, Beris P, Hadengue A (2000) Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis. J Med Virol 60:21-27
24. Thorburn D, Curry G, Spooner R, Spence E, Oien K, Halls D, Fox R, McCruden EA, MacSween RN, Mills PR (2002) The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 50:248-252
25. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 95:1472-1477
26. Riedel HD, Muckenthaler MU, Gehrke SG, Mohr I, Brennan K, Herrmann T, Fitscher BA, Hentze MW, Stremmel W (1999) HFE downregulates iron uptake from transferrin and induces iron-regulatory protein activity in stably transfected cells. Blood 94:3915-3921
27. Van Landeghem GF, Beckman LE, Wahlin A, Markevärn B, Beckman L (1998) Interaction between hemochromatosis and transferrin receptor genes in multiple myeloma. Lancet 352:1285-1286
28. Beckman LE, Van Landeghem GF, Sikström C, Wahlin A, Markevärn B, Hallmans G, Lenner P, Athlin L, Stenling R, Beckman L (1999) Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders. Carcinogenesis 20:1231-1233
29. Beckman LE, Hägerstrand I, Stenling R, Van Landeghem GF, Beckman L (2000) Interaction between haemochromatosis and transferrn receptor genes in hepatocellular carcinoma. Oncology 59:317-322
30. Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24:289-293
31. Von Ahsen N, Schutz E, Armstrong VW, Oellerich M (1999) Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler. Clin Chem 45:694-696
32. Bataller R, North KE, Brenner DA (2003) Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 37:493-503
33. Izumi N, Enomoto N, Uchihara M, Murakami T, Ono K, Noguchi O, Miyake S, Nouchi T, Fujisawa K, Marumo F, Sato C (1996) Hepatic iron contents and response to interferon-α in patients with chronic hepatitis C-relationship to genotypes of hepatitis C virus. Dig Dis Sci 41:989-994